Dartmouth-Hitchcock researchers investigate treatment for COVID-19
As hospitals around the world prepare for a surge of new COVID-19 patients, researchers at the Dartmouth-Hitchcock Medical Center are working on a possible treatment.
At this point, doctors are not saying how many patients are involved in the trial or how well they are doing, but they do seem optimistic about a drug that has already been used to fight viruses.
DHMC is one of 97 clinical sites around the world testing the drug Remdesivir. It's an anti-viral drug that was used to fight the Ebola virus, as well as SARS and MERS.
Hospital officials say if the trial is effective, the drug would likely be used to treat patients early on in their diagnosis which could free up beds for those in need of critical care.
"Now that would be an extraordinarily exciting thing if they have this as an option, if, of course, the treatment does show some efficacy. And that is, of course, an if because we are in the middle of researching this drug, it's not by any means a proven treatment right now," said Dr. Richard Zuckerman of DHMC.
Doctors say they hope to start analyzing the data in the very near future and have preliminary results in the next few weeks.
If the drug were to be deemed effective, it would still need FDA approval.